These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 15992521)

  • 1. Impact of schizophrenia and chronic antipsychotic treatment on [123I]CNS-1261 binding to N-methyl-D-aspartate receptors in vivo.
    Bressan RA; Erlandsson K; Stone JM; Mulligan RS; Krystal JH; Ell PJ; Pilowsky LS
    Biol Psychiatry; 2005 Jul; 58(1):41-6. PubMed ID: 15992521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of NMDA receptors in vivo in schizophrenic patients with [123I]CNS 1261 and SPET: preliminary findings.
    Bressan RA; Erlandsson K; Mulligan RS; Gunn RN; Cunningham VJ; Owens J; Ell PJ; Pilowsky LS
    Ann N Y Acad Sci; 2003 Nov; 1003():364-7. PubMed ID: 14684462
    [No Abstract]   [Full Text] [Related]  

  • 3. Relationship between ketamine-induced psychotic symptoms and NMDA receptor occupancy: a [(123)I]CNS-1261 SPET study.
    Stone JM; Erlandsson K; Arstad E; Squassante L; Teneggi V; Bressan RA; Krystal JH; Ell PJ; Pilowsky LS
    Psychopharmacology (Berl); 2008 Apr; 197(3):401-8. PubMed ID: 18176855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First in vivo evidence of an NMDA receptor deficit in medication-free schizophrenic patients.
    Pilowsky LS; Bressan RA; Stone JM; Erlandsson K; Mulligan RS; Krystal JH; Ell PJ
    Mol Psychiatry; 2006 Feb; 11(2):118-9. PubMed ID: 16189506
    [No Abstract]   [Full Text] [Related]  

  • 5. Ketamine displaces the novel NMDA receptor SPET probe [(123)I]CNS-1261 in humans in vivo.
    Stone JM; Erlandsson K; Arstad E; Bressan RA; Squassante L; Teneggi V; Ell PJ; Pilowsky LS
    Nucl Med Biol; 2006 Feb; 33(2):239-43. PubMed ID: 16546678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of a glycine transporter-1 inhibitor and D-serine on MK-801-induced immobility in the forced swimming test in rats.
    Kawaura K; Koike H; Kinoshita K; Kambe D; Kaku A; Karasawa J; Chaki S; Hikichi H
    Behav Brain Res; 2015 Feb; 278():186-92. PubMed ID: 25300471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A bolus/infusion paradigm for the novel NMDA receptor SPET tracer [123I]CNS 1261.
    Bressan RA; Erlandsson K; Mulligan RS; Gunn RN; Cunningham VJ; Owens J; Cullum ID; Ell PJ; Pilowsky LS
    Nucl Med Biol; 2004 Feb; 31(2):155-64. PubMed ID: 15013480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of sub-chronic clozapine and haloperidol administration on isolation rearing induced changes in frontal cortical N-methyl-D-aspartate and D1 receptor binding in rats.
    Toua C; Brand L; Möller M; Emsley RA; Harvey BH
    Neuroscience; 2010 Jan; 165(2):492-9. PubMed ID: 19854242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is regionally selective D2/D3 dopamine occupancy sufficient for atypical antipsychotic effect? an in vivo quantitative [123I]epidepride SPET study of amisulpride-treated patients.
    Bressan RA; Erlandsson K; Jones HM; Mulligan R; Flanagan RJ; Ell PJ; Pilowsky LS
    Am J Psychiatry; 2003 Aug; 160(8):1413-20. PubMed ID: 12900302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antipsychotic-like effects of the N-methyl-D-aspartate receptor modulator neboglamine: an immunohistochemical and behavioural study in the rat.
    Chiusaroli R; Garofalo P; Espinoza S; Neri E; Caselli G; Lanza M
    Pharmacol Res; 2010 May; 61(5):430-6. PubMed ID: 20045056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-HT2A receptor blockade in patients with schizophrenia treated with risperidone or clozapine. A SPET study using the novel 5-HT2A ligand 123I-5-I-R-91150.
    Travis MJ; Busatto GF; Pilowsky LS; Mulligan R; Acton PD; Gacinovic S; Mertens J; Terrière D; Costa DC; Ell PJ; Kerwin RW
    Br J Psychiatry; 1998 Sep; 173():236-41. PubMed ID: 9926100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clozapine blunts N-methyl-D-aspartate antagonist-induced psychosis: a study with ketamine.
    Malhotra AK; Adler CM; Kennison SD; Elman I; Pickar D; Breier A
    Biol Psychiatry; 1997 Oct; 42(8):664-8. PubMed ID: 9325559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clozapine, but not haloperidol, prevents the functional hyperactivity of N-methyl-D-aspartate receptors in rat cortical neurons induced by subchronic administration of phencyclidine.
    Arvanov VL; Wang RY
    J Pharmacol Exp Ther; 1999 May; 289(2):1000-6. PubMed ID: 10215680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetic modelling of [123I]CNS 1261--a potential SPET tracer for the NMDA receptor.
    Erlandsson K; Bressan RA; Mulligan RS; Gunn RN; Cunningham VJ; Owens J; Wyper D; Ell PJ; Pilowsky LS
    Nucl Med Biol; 2003 May; 30(4):441-54. PubMed ID: 12767402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. D-serine added to clozapine for the treatment of schizophrenia.
    Tsai GE; Yang P; Chung LC; Tsai IC; Tsai CW; Coyle JT
    Am J Psychiatry; 1999 Nov; 156(11):1822-5. PubMed ID: 10553752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clozapine, single photon emission tomography, and the D2 dopamine receptor blockade hypothesis of schizophrenia.
    Pilowsky LS; Costa DC; Ell PJ; Murray RM; Verhoeff NP; Kerwin RW
    Lancet; 1992 Jul; 340(8813):199-202. PubMed ID: 1353135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic administration of MK-801 produces an abnormally persistent latent inhibition which is reversed by clozapine but not haloperidol.
    Gaisler-Salomon I; Weiner I
    Psychopharmacology (Berl); 2003 Apr; 166(4):333-42. PubMed ID: 12599023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clozapine reverses schizophrenia-related behaviours in the metabotropic glutamate receptor 5 knockout mouse: association with N-methyl-D-aspartic acid receptor up-regulation.
    Gray L; van den Buuse M; Scarr E; Dean B; Hannan AJ
    Int J Neuropsychopharmacol; 2009 Feb; 12(1):45-60. PubMed ID: 18593507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iodine-123-iodobenzamide SPECT assessment of dopamine D2 receptor occupancy in riperidone-treated schizophrenic patients.
    Dresel S; Tatsch K; Dähne I; Mager T; Scherer J; Hahn K
    J Nucl Med; 1998 Jul; 39(7):1138-42. PubMed ID: 9669383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-Methyl-D-aspartate receptors as a target for improved antipsychotic agents: novel insights and clinical perspectives.
    Millan MJ
    Psychopharmacology (Berl); 2005 Apr; 179(1):30-53. PubMed ID: 15761697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.